112 related articles for article (PubMed ID: 31858551)
1. MiRNA-300 suppresses proliferation, migration and invasion of non-small cell lung cancer via targeting ETS1.
Yang YB; Tan H; Wang Q
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10827-10834. PubMed ID: 31858551
[TBL] [Abstract][Full Text] [Related]
2. MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2.
Tan T; Xu XH; Lu XH; Wang XW
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):712-720. PubMed ID: 32016973
[TBL] [Abstract][Full Text] [Related]
3. MiRNA-20a-5p accelerates the proliferation and invasion of non-small cell lung cancer by targeting and downregulating KLF9.
Fang QY; Deng QF; Luo J; Zhou CC
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2548-2556. PubMed ID: 32196605
[TBL] [Abstract][Full Text] [Related]
4. miR‑512‑5p suppresses proliferation, migration and invasion, and induces apoptosis in non‑small cell lung cancer cells by targeting ETS1.
Cao B; Tan S; Tang H; Chen Y; Shu P
Mol Med Rep; 2019 May; 19(5):3604-3614. PubMed ID: 30896817
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis.
Hao XZ; Yang K
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7399-7407. PubMed ID: 31539127
[TBL] [Abstract][Full Text] [Related]
6. LncRNA AWPPH accelerates the progression of non-small cell lung cancer by sponging miRNA-204 to upregulate CDK6.
Wu D; Qin BY; Qi XG; Hong LL; Zhong HB; Huang JY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4281-4287. PubMed ID: 32373964
[TBL] [Abstract][Full Text] [Related]
7. Circ0021205 aggravates the progression of non-small cell lung cancer by targeting miRNA-16-5p/VEGFA.
Yang Y; Huang XJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):213-221. PubMed ID: 31957834
[TBL] [Abstract][Full Text] [Related]
8. LncRNA HANR aggravates the progression of non-small cell lung cancer via mediating miRNA-140-5p.
Li SJ; Wu YX; Liang YH; Gao Y; Wu AB; Zheng HY; Yang ZX
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):704-711. PubMed ID: 32016972
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-19a promotes proliferative and migratory abilities of NSCLC cells by inhibiting PTEN expression.
Shi J; Han Y; Lin D; Wang K; Liu B; Gao C
J BUON; 2019; 24(3):955-962. PubMed ID: 31424647
[TBL] [Abstract][Full Text] [Related]
10. LncRNA CASC19 promotes the proliferation, migration and invasion of non-small cell lung carcinoma via regulating miRNA-130b-3p.
Qu CX; Shi XC; Zai LQ; Bi H; Yang Q
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):247-255. PubMed ID: 31389608
[TBL] [Abstract][Full Text] [Related]
11. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
12. LINC00922 Accelerates the Proliferation, Migration and Invasion of Lung Cancer Via the miRNA-204/CXCR4 Axis.
Liang T; Wang B; Li J; Liu Y
Med Sci Monit; 2019 Jul; 25():5075-5086. PubMed ID: 31287095
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621.
Chen ZY; Liu HY; Jiang N; Yuan JM
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9939-9946. PubMed ID: 31799663
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-455 suppresses non-small cell lung cancer through targeting ZEB1.
Li YJ; Ping C; Tang J; Zhang W
Cell Biol Int; 2016 Jun; 40(6):621-8. PubMed ID: 26801503
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.
Xu W; Hang M; Yuan CY; Wu FL; Chen SB; Xue K
Int J Clin Exp Pathol; 2015; 8(4):3864-70. PubMed ID: 26097570
[TBL] [Abstract][Full Text] [Related]
17. MiRNA-621 inhibits the malignant progression of non-small cell lung cancer via targeting SIX4.
Zhang M; Shi H; Zhang C; Zhang SQ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4807-4814. PubMed ID: 31210312
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-326 inhibits cell proliferative capacity and invasiveness through inhibiting the expression of ETS1 in nasopharyngeal carcinoma.
Zhao X; Zhang XJ; Li L; Xia ST; Cheng L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):181-188. PubMed ID: 31957831
[TBL] [Abstract][Full Text] [Related]
20. MAGI1-IT1 stimulates proliferation in non-small cell lung cancer by upregulating AKT1 as a ceRNA.
Zhang G; Chen HX; Yang SN; Zhao J
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):691-698. PubMed ID: 32016970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
